Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Apr 11.
Published in final edited form as: Angew Chem Int Ed Engl. 2016 Mar 9;55(16):4972–4976. doi: 10.1002/anie.201600638

Total Chemical Synthesis of Phosphorylated Histone H2A at Tyr57 Reveals Insight into the Inhibition Mode of the SAGA Deubiquitinating Module

Muhammad Jbara 1, Suman Kumar Maity 1, Michael Morgan 2, Cynthia Wolberger 2,, Ashraf Brik 1,
PMCID: PMC4944388  NIHMSID: NIHMS799820  PMID: 26960207

Abstract

Monoubiquitination of histone H2B plays a central role in transcription activation and is required for downstream histone methylation events. Deubiquitination of H2B by the Spt-Ada-Gcn5 acetyltransferase (SAGA) coactivator complex is regulated by a recently discovered histone mark, phosphorylated H2AY57 (H2AY57p), which inhibits deubiquitination of H2B by the SAGA complex as well as restricting demethylation of H3 and increasing its acetylation. Evidence for the effect of H2AY57p however, was indirect and was investigated in vivo by monitoring the effects of chemical inhibition of Tyr kinase CK2 or by mutating the phosphorylation site. We applied total chemical synthesis of proteins to prepare H2AY57p efficiently and study the molecular details of this regulation. This analogue, together with the semisynthetically prepared ubiquitinated H2B enabled us to provide direct evidence on the cross talk between those two marks and the inhibition of SAGA activity by H2AY57p.

Keywords: H2A histone, Phosphorylation, Deubiquitination, Chemical protein synthesis, SAGA DUB module

Two in one

graphic file with name nihms799820u1.jpg

Total chemical synthesis of proteins enabled the efficient preparation of homogeneously phosphorylated H2A at Tyr57 via one-pot synthesis. The assembly of phosphorylated H2A and ubiquitinated H2B with H3 and H4 into nucleosome, provided direct evidence for the inhibition of the activity of SAGA complex known to cleave ubiquitin from H2B.


Genetic information is stored in eukaryotes as a nucleoprotein complex known as chromatin, whose repeating unit is called the nucleosome.[1] Each nucleosome comprises approximately 146 base pairs of DNA wrapped twice around a histone octamer core consisting of two copies each of the four histone proteins, H2A, H2B, H3 and H4. Reversible posttranslational modifications (PTMs) of histones such as methylation, acetylation, phosphorylation and ubiquitination play a central role in regulating all processes requiring access to the genomic DNA in its chromatin context.[2] Mono-ubiquitination of histone H2B, for example, plays important roles in transcription activation, elongation, mRNA splicing and export, as well as in DNA replication and DNA damage repair.[3] H2B ubiquitination at Lys120 (H2BK120Ub) stimulates methylation of Lys79 methylation of H3 by the DOT1 histone methyl transferase[4] and Lys4 methylation of H3 by Set1.[5] Histone H2BK120 (in humans; Lys123 in yeast) is deubiquitinated by the Spt-Ada-Gcn5 acetyltransferase (SAGA) complex, a transcriptional co-activator complex that contains a four protein subcomplex (Ubp8/Sgf11/Sus1/Sgf73), known as the deubiquitinating module (DUBm) that cleaves ubiquitin from histone H2B.[6]

Several studies have shown that phosphorylation of various H2A residues is involved in regulating a variety of biological processes, such as DNA double-strand break repair.[7] Phosphorylation of Ser121 of H2A, for example, was reported to prevent chromosome instability[8] while phosphorylation of Ser1 inhibits transcription on a chromatin template.[9] Very recently, a new conserved phosphorylation site in human histone H2A at Tyr57 (H2AY57p) was discovered.[10] Phosphorylation of H2AY57 was found to inhibit deubiquitination of H2B by the SAGA complex as well as restricting demethylation of histone marks Lys4 and Lys79 and increasing acetylation of Lys27 in H3.[10] Evidence for the effect of phosphorylated H2AY57 however, was indirect and was investigated in vivo by monitoring the effects of chemical inhibition of Tyr kinase CK2 or by mutating the phosphorylation site.[10] A barrier to obtaining molecular insights into the impact of phosphorylated H2AY57 on deubiquitination by the SAGA DUBm is the difficulty in obtaining H2A homogenously phosphorylated at Tyr57, as well as the absence of any suitable amino acid mimic of phosphotyrosine. Such a study would also require H2B homogenously modified by the covalent attachment of ubiquitin to Lys120 (H2BK120Ub) and the assembly of nucleosomes containing the two desired modifications, which could then be used for further biochemical analysis. To answer this question, among many others, obtaining homogeneous H2AY57p and H2BK120Ub is an essential starting point.

Posttranslationally modified histones can be prepared homogeneously either by total chemical synthesis or by semisynthetic methods[11] where native chemical ligation (NCL) is applied to assemble the peptide fragments and construct the full protein sequence.[12] In semisynthetic methods, the histone-derived peptides containing the desired PTMs (generally at the N- or C-terminal region) are synthesized chemically and subsequently ligated with recombinantly prepared complimentary fragments. Thus, the application of this method is limited mainly for N- or C-terminally modifications. For example, our group[13] as well as the Muir group[14] used semisynthesis to assemble H2B bearing ubiquitin at its C-terminal region to assist numerous studies aiming at deciphering the role of ubiquitination in chromatin context. On the other hand, a total chemical synthesis approach, whereby the entire modified protein is synthesized via the assembly of synthetic peptides generated by solid phase peptide synthesis (SPPS), makes it possible to incorporate unlimited variations in the protein sequence, including the installation of PTMs at any desired position(s).[15]

In thinking about the preparation of H2AY57p modified histone, it was obvious to us that chemical total chemical protein synthesis would be the most efficient way to prepare this relatively small protein, which is composed of 130 residues. Here we report the efficient total chemical synthesis of the H2AY57p, in one-pot fashion, which allowed the characterization of the SAGA deubiquitination of H2BK120Ub in the context of a nucleosome.

To chemically synthesize H2AY57p, the polypeptide was divided into three fragments, Cys-H2A(88–130), fragment 1, Thz-H2AY57p(49–86), fragment 2, and H2A(1–47), fragment 3, (Scheme 1).

Scheme 1.

Scheme 1

A) H2A sequence. B) Schematic presentation of the synthesis of H2AY57p in one pot fashion.

The N-terminal Ala in fragments 2 and 3 were temporary mutated to Cys to enable NCL, wherein the N-terminal Cys of fragment 2 was protected as thiazolidine (Thz) to prevent cyclization or self-ligation during ligation process. The fragments 2 and 3, in their thioester forms, were prepared using N-acylurea[16] and N-methylcysteine[17] methods, respectively. Notably, in case of fragment 2, the cyclization of 3,4-diaminobenzoic acid (Dbz) was unsuccessful via standard conditions in dichloromethane. However, the use of N,N-dimethylformamide allowed the efficient cyclization of the Dbz and afforded the N-acylurea peptide with the additional 28 Da mass due to formylation of the N-acylurea moiety via Vilsmeier–Haack reaction.[18] On the other hand, fragment 3, which bears the C-terminal Gly, was prepared by the N-methylcysteine strategy, since the N-acylurea method in this case would require extra protection/deprotecation steps[19] of the free amine on Dbz to avoid any possible branching during Fmoc-based solid phase peptide (Fmoc-SPPS).[20] All peptides were synthesized using Fmoc-SPPS in high purity and with good yields (~40–50%) (Supporting Infromation).

With all fragments in hand, the first ligation between peptides 1 and 2 was performed in the presence of 4-mercaptophenylacetic acid (MPAA) and tris(2-carboxyethyl)phosphine hydrochloride (TCEP·HCl) in 6 M Gn·HCl, pH~7.2 (Figure 1). After completion of the ligation reaction in 4h, the mixture was treated with MeONH2·HCl at pH~4 for 10 h to convert Thz protecting group in ligation product to Cys-H2A(48–130), 4. Prior to the second ligation, the pH of the reaction mixture was adjusted to ~7.2 using NaOH. Fragment 3 was dissolved in a freshly prepared MPAA/TCEP solution and was added to the ligation mixture to enable the second ligation in one-pot manner, which furnished the ligation product 5, H2AY57p(1–130), in 1h. Notably, despite the presence of methoxylamine, in the second ligation only a minor amount of the side product generated from the attack of methoxylamine on fragment 3 was observed.[15a, 15b, 21] This is probably due to the rapid ligation reaction between fragments 3 and 4. Subsequently, one-pot desulfurization[22] was carried out in presence of the initiator 2,2′-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-044), TCEP and t-BuSH for 3h to produce the full length histone H2AY57p in ~25% isolated yield (Figure 1). The purified synthetic H2AY57p (Figure 2A) was examined by circular dichrosim (CD), which exhibited the expected CD signature of folded H2A (Figure 2B).

Figure 1.

Figure 1

Analytical HPLC and mass traces for chemically prepared H2AY57p. A) Ligation of fragments 1 and 2, peak a corresponds to 1; peak c corresponds to 2, and peak b corresponds to ligation product 4 with the observed mass 9187.9 ± 0.8 Da, calcd 9186.7 Da (average isotopes). B) Ligation of fragments 3 and 4, peak d corresponds to side product by methoxylamine attack on thioester in peptide 3; peak e corresponds to 1 and the cross ligation product between fragments 1 and 3; peak g corresponds to cross ligation product between 2 and 3; peak h corresponds to 4; peak f corresponds to final ligation product of 1, 2 and 3 with the observed mass 14192.5 ± 1.2 Da calcd 14191.5 Da (average isotopes). C) Desulfurization of the ligation product: peak d′ corresponds to the desulfurized side product d, peak e′ corresponds to the desulfurized side product e, Peak i corresponds to the desulfurized protein H2AY57p, with the observed mass 14128.0 ± 1.3 Da, calcd 14127.3 Da (average isotopes).

Figure 2.

Figure 2

A) Analytical HPLC and mass traces for the purified H2AY57p with the observed mass 14128.0 ± 1.3 Da, calcd 14127.3 Da (average isotopes). B) CD spectra of H2AY57p. C) Histone octamers reconstituted with the indicated modifications show identical reconstitution efficiencies as determined by analytical size-exclusion chromatography. (* indicates the peak containing octamer, whereas ** corresponds to the H2A/H2B heterodimer peak).

In order to prepare the nucleosomal substrate needed to test the effect of H2AY57p on deubiquitination of H2BK120Ub, the synthesized H2AY57p was assembled into nucleosomes together with recombinant Xenopus laevis histones H3 and H4, H2BK120Ub and the Widom 601 DNA sequence.[23] Notably, H2BK120Ub was prepared using our previously reported semisynthetic approaches.[24] Histones H2BK120Ub, H3, H4, and either native H2A or synthetic H2AY57p were reconstituted into octamers and purified by size-exclusion chromatography as described (Figure 2C).[25] Histone octamers could be assembled with similar efficiencies irrespective of whether or not they contained unmodified or phosphorylated H2A, indicating that the modification does not interfere with histone refolding. The histone octamers were further reconstituted into nucleosome core particles (NCPs) by gradient salt dialysis in the presence of the Widom 601 DNA purified using standard methods.[25]

In order to determine the effect of H2AY57p on DUB module activity, we compared the ability of the yeast SAGA DUB module to cleave monoubiquitin from histone H2B using ubiquitinated nucleosomes that contained either H2AY57p or unmodified H2A (Figure 3). The yeast SAGA DUB module, comprising Ubp8, Sus1, Sgf11 and Sgf73 residues 1–104 was purified as described.[26] DUB module at a concentration of 200 nM was incubated with 1 uM nucleosome in buffer containing 50 mM HEPES pH 7.5, 150 mM NaCl, 5 mM dithiothreitol and 10 uM ZnSO4. Aliquots of the reaction mixture were removed at the indicated time points, quenched by the addition of sample buffer containing sodium dodecyl sulfate and β-mercaptoethanol and analyzed by gel electrophoresis as described.[27] Cleavage was assessed by comparing the disappearance of the higher molecular weight H2BK120Ub band and appearance of free ubiquitin (Figure 3). The rate at which ubiquitin was cleaved from histone H2B was significantly lower (an approximate 30-fold reduction) for H2BK120Ub in nucleosomes containing H2AY57p, directly implicating this mark in regulating of DUB module activity against H2BK120Ub.

Figure 3.

Figure 3

DUB module cleavage rates for ubiquitinated nucleosomes are significantly reduced in the presence of H2AY57p.

The ability of H2AY57p to interfere with cleavage of ubiquitin from H2BK120 agrees with our recently reported crystal structure of the SAGA DUB module bound to ubiquitinated nucleosomes.[27] Residue H2AY57 lies at the interface between the DUB module and its contact surface with histones H2A and H2B (Figure 4). In particular, molecular modeling[27] showed that a phosphate group covalently linked to H2AY57 is in a position to clash with Sgf11 residues Arg84 or Arg91, which are required for efficient H2B deubiquitinase activity.[27]

Figure 4.

Figure 4

Location of H2AY57p at the interface between the SAGA DUB module and the nucleosome. Modeling of H2AY57p into the structure of the DUB module bound to the ubiquitinated nucleosome (PDB ID: 4ZUX). Modeled side chain positions suggest that H2AY57p may interfere with docking of the DUB module on the nucleosome. [27]

In summary, the efficient total chemical synthesis of H2AY57p was achieved from three peptide fragments, which were combined together applying one-pot NCL-desulfurization to give the desired product in high homogeneity and in 25% overall isolated yield. Taking advantage of our ability to prepare H2BK120Ub, we were able for the first time to assemble nucleosomes containing these two unique modifications and study the effect of H2A phosphorylation on deubiquitination of histone H2B in a nucleosomal context. Our results provide the first evidence that phosphorylation of H2A directly inhibits deubiqutination by the SAGA DUB module and lays the foundation for further studies dissecting cross-talk between these two marks as well as other marks that are modulated by ubiquitination-deubiquitination. Our study also highlights the power of total chemical synthesis of proteins to understand the complex mechanism of the histone regulation by multiple reversible PTMs.

Supplementary Material

Supporting Information

Acknowledgments

Supported by grant GM-095822 from the National Institute of General Medical Sciences (C.W.) and by a Ruth L. Kirschstein National Research Service Award (M.M.). A. Brik is a Neubauer Professor and a Taub Fellow-Supported by the Taub Foundations. SKM thanks the Israel Council of Higher Education for a fellowship under the PBC program.

Footnotes

Supporting information for this article is given via a link at the end of the document.

Contributor Information

Prof. Cynthia Wolberger, Email: cwolberg@jhmi.edu.

Prof. Ashraf Brik, Email: abrik@technion.ac.il.

References

  • 1.a) Kornberg RD. Annu Rev Biochem. 1977;46:931–954. doi: 10.1146/annurev.bi.46.070177.004435. [DOI] [PubMed] [Google Scholar]; b) Muller MM, Muir TW. Chem Rev. 2015;115:2296–2349. doi: 10.1021/cr5003529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.a) Jenuwein T, Allis CD. Science. 2001;293:1074–1080. doi: 10.1126/science.1063127. [DOI] [PubMed] [Google Scholar]; b) Kim J, Hake SB, Roeder RG. Mol Cell. 2005;20:759–770. doi: 10.1016/j.molcel.2005.11.012. [DOI] [PubMed] [Google Scholar]; c) Zhou VW, Goren A, Bernstein BE. Nat Rev Genet. 2011;12:7–18. doi: 10.1038/nrg2905. [DOI] [PubMed] [Google Scholar]
  • 3.a) Pavri R, Zhu B, Li GH, Trojer P, Mandal S, Shilatifard A, Reinberg D. Cell. 2006;125:703–717. doi: 10.1016/j.cell.2006.04.029. [DOI] [PubMed] [Google Scholar]; b) Laribee RN, Fuchs SM, Strahl BD. Gene Dev. 2007;21:737–743. doi: 10.1101/gad.1541507. [DOI] [PubMed] [Google Scholar]; c) Fleming AB, Kao CF, Hillyer C, Pikaart M, Osley MA. Mol Cell. 2008;31:57–66. doi: 10.1016/j.molcel.2008.04.025. [DOI] [PubMed] [Google Scholar]; d) Fuchs G, Oren M. Biochim Biophys. 2014;1839:694–701. doi: 10.1016/j.bbagrm.2014.01.002. [DOI] [PubMed] [Google Scholar]
  • 4.McGinty RK, Kim J, Chatterjee C, Roeder RG, Muir TW. Nature. 2008;453:812–U812. doi: 10.1038/nature06906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.a) Wu LP, Zee BM, Wang YM, Garcia BA, Dou YL. Mol Cell. 2011;43:132–144. doi: 10.1016/j.molcel.2011.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Sun ZW, Allis CD. Nature. 2002;418:104–108. doi: 10.1038/nature00883. [DOI] [PubMed] [Google Scholar]
  • 6.Henry KW, Wyce A, Lo WS, Duggan LJ, Emre NCT, Kao CF, Pillus L, Shilatifard A, Osley MA, Berger SL. Gene Dev. 2003;17:2648–2663. doi: 10.1101/gad.1144003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Foster ER, Downs JA. FEBS J. 2005;272:3231–3240. doi: 10.1111/j.1742-4658.2005.04741.x. [DOI] [PubMed] [Google Scholar]
  • 8.Kawashima SA, Yamagishi Y, Honda T, Ishiguro K, Watanabe Y. Science. 2010;327:172–177. doi: 10.1126/science.1180189. [DOI] [PubMed] [Google Scholar]
  • 9.Zhang Y, Griffin K, Mondal N, Parvin JD. J Biol Chem. 2004;279:21866–21872. doi: 10.1074/jbc.M400099200. [DOI] [PubMed] [Google Scholar]
  • 10.Basnet H, Su XB, Tan YL, Meisenhelders J, Merkurjev D, Ohgi KA, Hunters T, Pillus L, Rosenfeld MG. Nature. 2014;516:267–271. doi: 10.1038/nature13736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.a) Siman P, Brik A. Org Biomol Chem. 2012;10:5684–5697. doi: 10.1039/c2ob25149c. [DOI] [PubMed] [Google Scholar]; b) Holt M, Muir T. Annu Rev Biochem. 2015;84:265–290. doi: 10.1146/annurev-biochem-060614-034429. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Dhall A, Chatterjee C. Acs Chem Biol. 2011;6:987–999. doi: 10.1021/cb200142c. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Maity SK, Jbara M, Brik A. J Pept Sci. 2016 doi: 10.1002/psc.2848. [DOI] [PubMed] [Google Scholar]
  • 12.Dawson PE, Muir TW, Clarklewis I, Kent SBH. Science. 1994;266:776–779. doi: 10.1126/science.7973629. [DOI] [PubMed] [Google Scholar]
  • 13.a) Long L, Thelen JP, Furgason M, Haj-Yahya M, Brik A, Cheng DM, Peng JM, Yao TT. J Biol Chem. 2014;289:8916–8930. doi: 10.1074/jbc.M114.551754. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Shema-Yaacoby E, Nikolov M, Haj-Yahya M, Siman P, Allemand E, Yamaguchi Y, Muchardt C, Urlaub H, Brik A, Oren M, Fischle W. Cell Rep. 2013;4:601–608. doi: 10.1016/j.celrep.2013.07.014. [DOI] [PubMed] [Google Scholar]; c) Fuchs G, Shema E, Vesterman R, Kotler E, Wolchinsky Z, Wilder S, Golomb L, Pribluda A, Zhang F, Haj-Yahya M, Feldmesser E, Brik A, Yu XC, Hanna J, Aberdam D, Domany E, Oren M. Mol Cell. 2012;46:662–673. doi: 10.1016/j.molcel.2012.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.a) Kim J, Kim JA, McGinty RK, Nguyen UTT, Muir TW, Allis CD, Roeder RG. Mol Cell. 2013;49:1121–1133. doi: 10.1016/j.molcel.2013.01.034. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Fierz B, Chatterjee C, McGinty RK, Bar-Dagan M, Raleigh DP, Muir TW. Nat Chem Biol. 2011;7:113–119. doi: 10.1038/nchembio.501. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) McGinty RK, Kohn M, Chatterjee C, Chiang KP, Pratt MR, Muir TW. Acs Chem Biol. 2009;4:958–968. doi: 10.1021/cb9002255. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Chatterjee C, McGinty RK, Fierz B, Muir TW. Nat Chem Biol. 2010;6:267–269. doi: 10.1038/nchembio.315. [DOI] [PubMed] [Google Scholar]
  • 15.a) Seenaiah M, Jbara M, Mali SM, Brik A. Angew Chem Int Ed. 2015;54:12374–12378. doi: 10.1002/anie.201503309. [DOI] [PubMed] [Google Scholar]; b) Siman P, Karthikeyan SV, Nikolov M, Fischle W, Brik A. Angew Chem Int Ed. 2013;52:8059–8063. doi: 10.1002/anie.201303844. [DOI] [PubMed] [Google Scholar]; c) Li JB, Li YY, He QQ, Li YM, Li HT, Liu L. Org Biomol Chem. 2014;12:5435–5441. doi: 10.1039/c4ob00715h. [DOI] [PubMed] [Google Scholar]; d) Wang JX, Fang GM, He Y, Qu DL, Yu M, Hong ZY, Liu L. Angew Chem Int Ed. 2015;54:2194–2198. doi: 10.1002/anie.201408078. [DOI] [PubMed] [Google Scholar]; e) Shimko JC, North JA, Bruns AN, Poirier MG, Ottesen JJ. J Mol Biol. 2011;408:187–204. doi: 10.1016/j.jmb.2011.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Blanco-Canosa JB, Dawson PE. Angew Chem Int Ed. 2008;47:6851–6855. doi: 10.1002/anie.200705471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Erlich LA, Kumar KSA, Haj-Yahya M, Dawson PE, Brik A. Org Biomol Chem. 2010;8:2392–2396. doi: 10.1039/c000332h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Siman P, Blatt O, Moyal T, Danieli T, Lebendiker M, Lashuel HA, Friedler A, Brik A. Chembiochem. 2011;12:1097–1104. doi: 10.1002/cbic.201100033. [DOI] [PubMed] [Google Scholar]
  • 19.Mahto SK, Howard CJ, Shimko JC, Ottesen JJ. Chembiochem. 2011;12:2488–2494. doi: 10.1002/cbic.201100472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.After the completion of this work, Dawson and coworkers reported a second generation N-methyl Dbz linker, which in principle should overcome these extra steps, for more details see: Blanco-Canosa JB, Nardone B, Albericio F, Dawson PE. J Am Chem Soc. 2015;137:7197–7209. doi: 10.1021/jacs.5b03504.
  • 21.a) Johnson ECB, Malito E, Shen YQ, Rich D, Tang WJ, Kent SBH. J Am Chem Soc. 2007;129:11480–11490. doi: 10.1021/ja072870n. [DOI] [PubMed] [Google Scholar]; b) Piontek C, Silva DV, Heinlein C, Pohner C, Mezzato S, Ring P, Martin A, Schmid FX, Unverzagt C. Angew Chem Int Ed. 2009;48:1941–1945. doi: 10.1002/anie.200804735. [DOI] [PubMed] [Google Scholar]
  • 22.Moyal T, Hemantha HP, Siman P, Refua M, Brik A. Chem Sci. 2013;4:2496–2501. [Google Scholar]
  • 23.Lowary PT, Widom J. J Mol Biol. 1998;276:19–42. doi: 10.1006/jmbi.1997.1494. [DOI] [PubMed] [Google Scholar]
  • 24.Haj-Yahya M, Eltarteer N, Ohayon S, Shema E, Kotler E, Oren M, Brik A. Angew Chem Int Ed. 2012;51:11535–11539. doi: 10.1002/anie.201205771. [DOI] [PubMed] [Google Scholar]
  • 25.Luger K, Rechsteiner TJ, Richmond TJ. Methods Mol Biol. 1999;119:1–16. doi: 10.1385/1-59259-681-9:1. [DOI] [PubMed] [Google Scholar]
  • 26.Samara NL, Datta AB, Berndsen CE, Zhang XB, Yao TT, Cohen RE, Wolberger C. Science. 2010;328:1025–1029. doi: 10.1126/science.1190049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Morgan M, Haj-Yahya M, Ringel AE, Bandi P, Brik A, Wolberger C. Science. 2016;351:725–728. doi: 10.1126/science.aac5681. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES